Re: Which Patients with Metastatic Hormone-sensitive Prostate Cancer Benefit from Docetaxel: A Systematic Review and Meta-analysis of Individual Participant Data from Randomised Trials. uri icon

Overview

publication date

  • December 11, 2023

Research

keywords

  • Antineoplastic Agents
  • Docetaxel
  • Prostatic Neoplasms
  • Randomized Controlled Trials as Topic

Identity

Scopus Document Identifier

  • 85179782033

Digital Object Identifier (DOI)

  • 10.1016/j.eururo.2023.11.007

PubMed ID

  • 38087732

Additional Document Info

volume

  • 85

issue

  • 3